Item 7.01. Regulation FD Disclosure.

On June 23, 2022, Novo Integrated Sciences, Inc. (the "Company") issued a press release announcing that Rob Mattacchione, CEO and Board Chairman, has been invited by the American Association of Physicians of Indian Origin (AAPI) to present during AAPI's 40th Annual Convention's CEO Forum to discuss advancing the Future of Healthcare: Technology, Transformation and Beyond, on Saturday June 25, 2022 at 4:30 p.m. CDT in San Antonio, Texas. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in Item 7.01 to this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description

99.1            Press release issued by the registrant on June 23, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses